Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 12, 2011, Pages 2036-2043

  Haasbeek, Cornelis J A ^a   Lagerwaard, Frank J ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early stage lung cancer; SABR; SBRT; Stereotactic radiotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; ATELECTASIS; BRONCHUS STENOSIS; CANCER CONTROL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COUGHING; DISTANT METASTASIS; DYSPNEA; EARLY CANCER; ESOPHAGITIS; FATIGUE; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG CANCER; LUNG HILUS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; OVERALL SURVIVAL; PERICARDIUM; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RIB FRACTURE; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC RADIOSURGERY; THORAX PAIN; THORAX WALL; TREATMENT OUTCOME; TUMOR ABLATION; TUMOR LOCALIZATION;

EID: 81755179379     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31822e71d8     Document Type: Article

References (38)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543. (Pubitemid 33586866)
2. Crino L, Weder W, van Meerbeeck J, et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:v103-v115.
3. Haasbeek CJ, Senan S, Smit EF, et al. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. Oncologist 2008;13:309-319. (Pubitemid 351679907)
4. Chi A, Liao Z, Nguyen NP, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage nonsmall-cell lung cancer: clinical implications. Radiother Oncol 2010;94: 1-11.
5. Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol 2011;23:133-139.
6. Palma D, Visser O, Lagerwaard FJ, et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-5159.
7. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004;60:1026-1032. (Pubitemid 39440785)
8. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-692.
9. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-S100. (Pubitemid 47183602)
10. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839. (Pubitemid 46630909)
11. Song SY, Choi W, Shin SS, et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 2009;66:89-93.
12. Fowler JF, Tome WA, Fenwick JD, et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241-1256. (Pubitemid 39440811)
13. Kestin LL, Grills IS, Guckenberger M, et al. Substantial dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Int J Radiat Oncol Biol Phys 2010;78:S14.
14. Kong FM, Ritter T, Quint DJ, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys [published ahead of print October 7, 2010] doi:10.1016/j.ijrobp.2010.07. 1977.
15. Goldstraw P. The 7th edition of TNM in lung cancer: what now? J Thorac Oncol 2009;4:671-673.
16. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomized trial. Lancet 2002;359:1388-1393.
17. Herder GJ, Kramer H, Hoekstra OS, et al. Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of nonsmall-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 2006;24:1800-1806. (Pubitemid 46638976)
18. Belgers EH, Siebenga J, Bosch AM, et al. Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands. Interact Cardiovasc Thorac Surg 2010;10:176-180.
19. Slotman BJ, Lagerwaard FJ, Senan S. 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncol 2006;45:966-972. (Pubitemid 44423147)
20. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys 2005;63:253-260. (Pubitemid 41583566)
21. Rietzel E, Pan T, Chen GT. Four-dimensional computed tomography: image formation and clinical protocol. Med Phys 2005;32:874-889. (Pubitemid 40586772)
22. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respirationgated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 2005;62:554-560. (Pubitemid 40704475)
23. Beddar AS, Briere TM, Balter P, et al. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol 2008;87:445-448.
24. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-87. (Pubitemid 41503394)
25. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: fouryear results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682.
26. Bral S, Gevaert T, Linthout N, et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial. Int J Radiat Oncol Biol Phys 2011;80:1343-1349.
27. Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treatment Rev 2008;34:719-727.
28. Miller KL, Shafman TD, Anscher MS, et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 2005;61:64-69. (Pubitemid 40039106)
29. Stripp D, Glatstein E. The good, the bad, and the ugly. Int J Radiat Oncol Biol Phys 2005;61:3-4. (Pubitemid 40039096)
30. Damhuis R, Coonar A, Plaisier P, et al. A case-mix model for monitoring of postoperative mortality after surgery for lung cancer. Lung Cancer 2006;51:123-129. (Pubitemid 43088632)
31. Arriagada R, Le CT, Quoix E, et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Federation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
32. Joyner M, Salter BJ, Papanikolaou N, et al. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 2006;45:802-807. (Pubitemid 44423125)
33. Milano MT, Chen Y, Katz AW, et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother Oncol 2009;91:301-306.
34. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135. (Pubitemid 36403684)
35. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-smallcell lung cancer. Int J Radiat Oncol Biol Phys 2006;66:117-125. (Pubitemid 44175645)
36. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;72:967-971.
37. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796-801. (Pubitemid 44423124)
38. Nuyttens J, Van der Voort van Zyp N, Hoogeman M, et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2010;96:S132-S133; Supplement 1.